Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.
Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mücke T, Mast G, Köhnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Stürzenbaum SR, Schieker M, Pautke C.
Otto S, et al. Among authors: abu id mh.
J Craniomaxillofac Surg. 2011 Jun;39(4):272-7. doi: 10.1016/j.jcms.2010.05.009. Epub 2010 Jul 2.
J Craniomaxillofac Surg. 2011.
PMID: 20580566
Review.
To date, research has primarily focused on the development and progression of BRONJ in cancer patients with bone metastasis, who have received high dosages of BPs intravenously. However, a potential dilemma may arise from a far larger cohort, namely the millions of osteopo …
To date, research has primarily focused on the development and progression of BRONJ in cancer patients with bone metastasis, who have receiv …